New FRONTIER5 data show that a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for…
June 20, 2025 17:26 ET | Source: Treatment.com AI Inc. VANCOUVER, British Columbia, June 20, 2025 (GLOBE NEWSWIRE) -- Treatment.com…
PANAMA CITY, June 20, 2025 /PRNewswire/ -- BingX, a leading cryptocurrency exchange and Web3 AI company, has officially launched its…
PFL-721 and PFL-241 are mutant-specific EGFR inhibitors with best-in-class potential, being developed as treatment options for emergent and unmet medical…
June 14, 2025 01:05 ET | Source: Avricore Health Inc. VANCOUVER, British Columbia, June 14, 2025 (GLOBE NEWSWIRE) -- AVRICORE…
LEXINGTON, Mass., June 13, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences…
June 13, 2025 16:01 ET | Source: Nurix Therapeutics, Inc. SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics,…
June 06, 2025 16:05 ET | Source: TELA Bio, Inc. MALVERN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- TELA Bio,…
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13)…
Enables investments without a linked savings account, with options from top banks and NBFCsOffers up to 9.1% interest and smart…